Hopkins Biotech Podcast
Hopkins Biotech Podcast
Outreach Signals
Publishing Details
About This Podcast
Social Media
Explore Statistics
Recent Episodes
Sickle Cell Disease: New Wave of Gene Therapies
Sickle cell disease was once considered an incurable disease, until recently. A wide variety of gene therapies have now become available, allowing patients with sickle cell disease to now have…
Roivant: Reinventing the Paradigm of Conventional Drug Development
Roivant Pharma is reinventing the discovery, development, and commercialization of new medicines. Mayukh Sukhatme, M.D. was recently appointed to Roivant's board of directors and has served as…
Public Relations and Scientific Communications for Biotechnology with Ignacio Guerrero-Ros
Dr. Ignacio Guerrero-Ros is an immunologist turned scientific communicator and biotech media innovator. Currently, he is an Assistant Vice President at Russo Partners, providing public and investor…
What You Should Know About the Biotech Job Market in 2023 with Carina Clingman
Carina Clingman, Ph.D., is the Founder and CEO of Recruitomics Consulting, a niche talent acquisition and talent strategy firm specializing in biotech startups. She recently founded The Collaboratory…
Antibody-Drug Conjugates: Targeting Cancer Where it is Vulnerable with David Dornan of Elevation Oncology
About this episode: David Dornan is the Chief Scientific Officer of Elevation Oncology, a clinical-stage biotech company developing targeted cancer therapeutics, with a focus on antibody drug…
Boston Biotech Series: Standing out in the Competitive Recruiting Process for Early Stage Biotech
Emily Gransky is the Vice President of Recruiting at RA Ventures (RAVen). RAVen is the early-stage venture arm of the multi-stage investment firm RA Capital. In this role, Emily works closely with…
Boston Biotech Series: Building a Drug Development Platform on New Biology with Isaac Klein of Dewpoint Therapeutics
Dr. Isaac Klein is the Chief Scientific Officer at Dewpoint Therapeutics. Dewpoint Therapeutics is leveraging condensate biology to impact a wide range of therapeutic targets across diverse disease…
Boston Biotech Series: Facilitating Start-up Company Formation with Adam Jenkins of Biolabs
Dr. Adam Jenkins is the Regional Site Director for the Massachusetts sites of Biolabs. BioLabs is an international, membership-based network of shared lab and office facilities located in key biotech…
JPM Highlights: What’s Next in ImmunoOncology
In this episode, we talk with our panel about updates their company gave at the recent JP Morgan Healthcare Conference that took place earlier this year. This once-yearly conference is the epicenter…
Lineage Cell Therapeutics: Building an Allogeneic Cell Transplant Therapy Platform
Brian Culley is the CEO of Lineage Cell Therapeutics, a clinical-stage biotech company whose mission is to pioneer a new branch of medicine based on transplanting specific cell types to patients with…
JPM Highlights: Overcoming Complications in Rare Disease Drug Development
In this episode, we talk with our panel about updates their company gave at the recent JP Morgan Healthcare Conference that took place earlier this year. This once-yearly conference is the epicenter…
Adrian Rubstein: translating science to business in the Latin American biotech ecosystem
Adrian is an advisor for several biotech companies in Argentina. Before joining CITES, a venture builder from Argentina, he worked as an advisor for RedCrow VC in San Francisco, and has more than 10…
Cyclacel Pharmaceuticals: Interventions for Cell Cycle Abnormalities in Cancer
Cyclacel Pharmaceuticals is a clinical-stage, biopharmaceutical company, developing innovative cancer medicines based on cell cycle, transcriptional regulation, and mitosis biology with a focus on…
Melatech: Unlocking Melanin’s Biotech Potential for the Benefit of Society in Earth and Space
Radamés Cordero is the CEO of Melatech and an associate scientist and junior faculty in the department of Molecular Microbiology and Immunology at Johns Hopkins Bloomberg School of Public Health…
Ratio Therapeutics: Math Meets Medicine in the Design of Radiotherapies
Ratio Therapeutics is a Boston-based pharmaceutical company with the mission to accelerate the development of best-in-class targeted radiotherapeutics for the treatment of cancers. By employing a…
Anupam Chakravarty: Building Community in the Graduate Education Landscape
Dr. Anupam Chakravarty is a researcher whose research interests have straddled the disciplines of biochemistry and genomics with a keen focus on the biology of cancer. Currently, he is a senior…
Tony Russo: A Multi-Decade View of the Biotechnology Industry
Dr. Tony Russo Ph.D. is the Chairman, CEO, and founder of Russo Partners, a leading public and investor relations firm. He has been a member of the healthcare and technology PR and IR community for…
Robert Hollingsworth: The Future of iPSC-based Cell Therapy Technology
Dr. Robert Hollingsworth is the current Chief Scientific Officer of Shoreline Biosciences, a biopharmaceutical company developing next-generation cellular immunotherapies based on induced pluripotent…
Shelley Ackerman: Immunotherapeutics Development in Graduate School
Dr. Shelley Ackerman is an Associate Director & Program Team Lead at Bolt Biotherapeutics. Bolt is a clinical-stage biotechnology company pioneering a new class of immuno-oncology agents that…
James Coates: Company Growth Through Strategic Advising
Dr. James Coates is currently the Principal for Health & Human Performance at Decisive Point, an East coast venture capital firm that invests in and supports startups with deep tech and…
Frequently Asked Questions
Hopkins Biotech Podcast has published 85 episodes since May 2020, covering topics in Business, Careers.
Hopkins Biotech Podcast is currently sporadic with new episodes every 2 weeks. Average episode length is 41m.
Sign up on Grep.FM to access contact details for Hopkins Biotech Podcast, including email and social media links.
Similar Podcasts
MSL Talk
MSL Talk Podcast
304 episodes
Science Careers for Moms | Women in STEM, Work-Life Balance, Career Goals, Career Planning, Decision Making
Anokhi Kapasi, PhD - Life Planning & Career Strategist for Women in STEM
118 episodes
THE EMBC NETWORK Featuring: ihealthradio and Worldwide Podcasts
Hurricane H
837 episodes
Her Intentional Reset
Molly Wipperfurth
14 episodes
Lab Rats to Unicorns
John Flavin
88 episodes
Reptile Talk
Jeremy Turgeon and Rob Christian
166 episodes